HSPA1A and gastric adenocarcinoma: HSPA1A CNVs were correlated with shorter survival time in stomach adenocarcinoma (HR = 1.317, OR = 1.044–1.661, p = 0.02) and esophageal carcinoma (HR = 1.386, OR = 1.007–1.908, p = 0.045).